Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy Opf Trexima in the Acute Treatment of Migraine Headaches

NCT00433732 is registered in ClinicalTrials.gov with POZEN as lead sponsor.

NCT NCT00433732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00433732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Multicenter, Randomized, Placebo-Controlled Single Dose Study to Evaluate the Safety and Efficacy Opf Trexima in the Acute Treatment of Migraine Headaches
Lead sponsor
POZEN
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2004
Completion date
April 30, 2005
Enrollment
1,400
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headaches